ORIC-114
- Generic Name
- ORIC-114
Effect of Food on the Pharmacokinetics of ORIC-114
- First Posted Date
- 2023-08-25
- Last Posted Date
- 2024-01-19
- Lead Sponsor
- ORIC Pharmaceuticals
- Target Recruit Count
- 32
- Registration Number
- NCT06012721
- Locations
- 🇦🇺
Nucleus Network Pty Ltd., 235 Ryrie St, Geelong, Victoria, Australia
🇦🇺Nucleus Network Pty Ltd., Level 5, Burnet Tower, 89 Commercial Rd, Melbourne, Victoria, Australia
Study of ORIC-114 in Patients with Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
- First Posted Date
- 2022-04-07
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- ORIC Pharmaceuticals
- Target Recruit Count
- 350
- Registration Number
- NCT05315700
- Locations
- 🇺🇸
City of Hope, Long Beach, California, United States
🇺🇸University of California, San Francisco, San Francisco, California, United States
🇺🇸Yale Cancer Center, New Haven, Connecticut, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath